Humana stock: buy or sell?
December 6th, 2019
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial.
Should I buy Humana stock?Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. That's why is so important to define your own trading strategy that fits your character as inversor. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Just 1 of our buy setups matches with Humana stock now:
|New all-time high||No|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Humana stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we detected 15 ratings published for HUM stock in the last 30 days. The general sentiment of these ratings is bullish for HUM stock, with 10 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-9-30||BMO Capital Markets||Outperform||Market Perform|
|2019-8-1||Piper Jaffray Companies||n/a||Overweight|
|2019-8-1||JPMorgan Chase & Co.||n/a||Overweight|
Humana stock analysis
Humana ended on Dec 6th at $348.14 and stepped up a tiny 0.85%.
Humana shares stepped up 0.85% to $348.14 on December 6th. On October, SMA100d and SMA200d crossed up triggering a rise of 20.36%. Since last October when HUM stock price broke up the SMA200d line, it gained $84.14 (31.87%).
Shares of Humana ended this week at $348.14 and stepped up a good 2.03%. Counting this, it's been 5 climbing weeks in a row, soaring a 18.03%. By mid November HUM skyrocketed a phenomenal 5.36% in just one week.
Weekly chart tells us that price finally broke over the resistance at $304.83 and continued climbing. Since SMA20d and SMA40w crossed up by mid October, HUM price climbed $81.88 per share (30.75%). By mid October HUM price bounced up over the SMA of 40 weeks that acted as support stopping new slides.
Humana stock price history
Humana IPO was on December 31st, 1981 at $1.97 per share1. Since then, HUM stock surged a 17,572.10%, with a yearly average of 474.90%. If you had invested $1,000 in Humana stock in 1981, it would worth $175,721.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Humana stock historical price chart
HUM stock reached 52-week highs on December/6 at $350.46, and all-time highs 2018-11-07 with a price of 353.03.
Humana stock price target is $327.50How much a stock will be priced tomorrow or next week is quite unpredictable However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 12 price targets for Humana stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-9-30||BMO Capital Markets||Downgrades||$345.00||$290.00||-15.9%|
|2019-9-26||Morgan Stanley||Lowers Target||$342.00||$337.00||-1.5%|
|2019-8-23||Morgan Stanley||Raises Target||$315.00||$342.00||8.6%|
|2019-8-1||UBS Group||Raises Target||$266.00||$317.00||19.2%|
|2019-8-1||SunTrust Banks||Raises Target||n/a||$340.00||-|
|2019-8-1||Piper Jaffray Companies||Raises Target||$315.00||$341.00||8.3%|
|2019-8-1||JPMorgan Chase & Co.||Raises Target||$288.00||$322.00||11.8%|
|2019-7-12||Morgan Stanley||Lowers Target||$331.00||$315.00||-4.8%|
|2019-5-2||SunTrust Banks||Lowers Target||n/a||$300.00||-|
|2019-5-2||Morgan Stanley||Set Price Target||n/a||$331.00||-|
Financials and fundamental analysis
Earnings date and Earnings per ShareSince last April, when Humana published its last earnings report, it . As soon as we get its actual EPS from the earnings report, we will update this review.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Humana annual revenues soared a decent 5.85% to $56,912.00 million dollars from $53,767.00 marked in 2017. When comparing 2018 vs 2017, instead, profit margin (that is, the net income divided by revenues) slightly fell a -1.60% to 2.96%. To have an updated picture of the financial situation of Humana, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Humana TTM sales up to March 2019 were $58,740.00 and income was $1,758.00 M dollars. If we compare this TTM figures with the last reported annuality, we can esteem Humana business evolution since December 2018: Annual sales up to March, compared to lastest yearly report, grew a fine 3.21%. Regarding profit margin, Humana remained stable 0.04% to 2.96%
|2013||$41,310 M||-||$1,230 M3.0%||-|
|2014||$48,500 M||17.40%||$1,147 M2.4%||-6.75%|
|2015||$54,289 M||11.94%||$1,276 M2.4%||11.25%|
|2016||$54,379 M||0.17%||$614 M1.1%||-51.88%|
|2017||$53,767 M||-1.13%||$2,448 M4.6%||298.70%|
|2018||$56,912 M||5.85%||$1,683 M3.0%||-31.25%|
|TTM||$58,740 M||3.21%||$1,758 M3.0%||4.46%|
Quarterly financial resultsHumana posted $16,107.00 M in revenues for 2019-Q1, a 13.69% improvement compared to previous quarter. Reported quarter income marked $566.00 million with a profit margin of 3.51%. Profit margin appreciated a 1.01% compared to previous quarter when profit margin was 2.51%. When comparing sales to same quarter last year, Humana sales marked an amazing growth and skyrocketed a 12.80%.
|2017-Q2||$13,530 M||-||$650 M4.8%||-|
|2017-Q3||$13,282 M||-1.83%||$499 M3.8%||-23.23%|
|2017-Q4||$13,189 M||-0.70%||$184 M1.4%||-63.13%|
|2018-Q1||$14,279 M||8.26%||$491 M3.4%||166.85%|
|2018-Q2||$14,259 M||-0.14%||$193 M1.4%||-60.69%|
|2018-Q3||$14,206 M||-0.37%||$644 M4.5%||233.68%|
|2018-Q4||$14,168 M||-0.27%||$355 M2.5%||-44.88%|
|2019-Q1||$16,107 M||13.69%||$566 M3.5%||59.44%|
Humana ownershipWhen you are planning to invest in a company, it's worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Humana, 0.20% of all outstanding shares are owned by its staff.
Bearish positions for HUM stock account 0.00%, no big difference from last month.
For a better understanding, the following table shows ownership data compared to other related stocks:
|Market cap||$46.1 B||$72.3 B||$25.2 B||$8.4 B||$265.5 B|
|Total shares||132.4 M||253.6 M||413.8 M||62.7 M||947.4 M|
|Float shares||132.0 M||253.2 M||405.8 M||58.0 M||940.4 M|
|- Institutional holdings (%)||96.4%||91.4%||92.3%||106.5%||88.2%|
|- Insider holdings (%)||0.2%||0.2%||2.4%||0.8%||0.6%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Friday, December 6th, 2019|
|Day range||$345.30 - $350.46|
|Average true range||$5.77|
|50d mov avg||$300.75|
|100d mov avg||$291.76|
|200d mov avg||$276.22|
Humana performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. We chose Anthem, Centene, Molina Healthcare and UnitedHealth as the bechmarking frame for Humana stock.
Humana competitorsOne check before investing in any stock is to have a look a list of its competitors, in this case for Humana. We chose 4 companies as Humana competitors as they are in the same industry or have similar market objectives.
Latest Humana stock news
- Seeking AlphaHumana Set To Recover Losses Or Is Medicare For All A Threat?April 29, 2019
- Seeking AlphaHumana Inc.: An Intact Growth Story For A Decent Price?April 1, 2019
- Seeking AlphaPositive Earnings Report, Growth In Its Flagship Product And Focus On Personalised Health: Humana A Strong Growth Proposition For Short To Medium TermFebruary 26, 2019